These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38066772)

  • 1. Lipid Profile Paradox: Investigating Improved Lipid Levels in Diabetic Mellitus Patients with Foot Ulcer Infections-A Prospective Descriptive Study.
    Ardelean A; Neamtu AA; Balta DF; Neamtu C; Goldis D; Rosu M; Nesiu A; Moldovan S; Tarta C; Totolici BD
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial.
    Bevilacqua M; Guazzini B; Righini V; Barrella M; Toscano R; Chebat E
    Curr Ther Res Clin Exp; 2004 Jul; 65(4):330-44. PubMed ID: 24672088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
    Lewin AJ; Kipnes MS; Meneghini LF; Plotkin DJ; Perevozskaya IT; Shah S; Maccubbin DL; Mitchel YB; Tobert JA;
    Clin Ther; 2004 Mar; 26(3):379-89. PubMed ID: 15110130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.
    Yang T; Liu Y; Li L; Zheng Y; Wang Y; Su J; Yang R; Luo M; Yu C
    Cardiovasc Diabetol; 2022 Jun; 21(1):93. PubMed ID: 35659300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.
    Gouni-Berthold I; Giannakidou E; Faust M; Berthold HK; Krone W
    Atherosclerosis; 2005 Dec; 183(2):336-41. PubMed ID: 16285997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia Among Diabetes Mellitus Patients: A Case-Control Study From a Tertiary Care Hospital in South India.
    Latha VA; Mondu SSD; Dinesh Eshwar M; Polala AR; Nandanavanam S; Dodda S
    Cureus; 2023 Feb; 15(2):e35625. PubMed ID: 37007365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
    Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
    Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
    Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrophotometry and Ultracentrifugation for Measurement of Plasma Lipids in Dogs with Diabetes Mellitus.
    Seage EC; Drobatz KJ; Hess RS
    J Vet Intern Med; 2018 Jan; 32(1):93-98. PubMed ID: 29193277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on fasting and postprandial lipid profile in type 2 diabetes mellitus.
    Chahal J; Gupta S; Chawla SPS; Grewal H
    J Family Med Prim Care; 2021 Mar; 10(3):1288-1293. PubMed ID: 34041167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.
    Colhoun HM; Leiter LA; Müller-Wieland D; Cariou B; Ray KK; Tinahones FJ; Domenger C; Letierce A; Israel M; Samuel R; Del Prato S
    Cardiovasc Diabetol; 2020 Feb; 19(1):14. PubMed ID: 32035487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentraxin-3 and Other Inflammatory Markers for an Infected Diabetic Foot Ulcer Diagnosis: A Prospective Study.
    Ardelean A; Balta DF; Neamtu C; Neamtu AA; Rosu M; Pilat L; Moldovan S; Tarta C; Totolici B
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrence and influencing factors of diabetic foot ulcer in patients with type 2 diabetes mellitus].
    Shen JF; Jiang RM; Wang ZQ; Li M; Li J; Xie SY; Kang JJ
    Zhonghua Shao Shang Za Zhi; 2020 Oct; 36(10):947-952. PubMed ID: 33105947
    [No Abstract]   [Full Text] [Related]  

  • 18. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
    Selim S; Alam MS; Talukder SK; Kabir ML; Gaffar AJ; Kabir MA; Zarin N; Rahman S; Nabi MMU; Mustari M; Hossain MF; Raunak AIB; Hoque MA; Islam MR; Akter F; Hannan MA; Saifuddin M; Asaduzzaman M; Rahman MM; Ahammed A; Rafi MA; Hasan MJ; Kamrul-Hasan ABM
    BMC Endocr Disord; 2023 Dec; 23(1):268. PubMed ID: 38053073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Weiss R; Harder M; Rowe J
    Clin Ther; 2003 May; 25(5):1490-7. PubMed ID: 12867223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.